CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 117 enrolled
Drug / intervention
Betacarotene +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01477112
NCT01477112N/ACompleted
CompareCT.gov

Effect of the Supplementation With β-carotene to Type 2 Diabetic Patients and Healthy Controls on the Iron Status and Antioxidant Capacity of Plasma

Instituto Venezolano de Investigaciones Cientificas·interventional·Posted Nov 22, 2011·Updated Nov 22, 2011

In Brief

A clinical study evaluating Betacarotene and Controls. No treatment for Diabetes Mellitus and 2 related conditions. Completed, enrolled 117 participants across 1 site.

Detailed Summary

Since diabetes has multiple etiologies and oxidative stress one of the proposed mechanisms, the objective is to determine the effect of supplementation with β-carotene to type 2 diabetics and healthy individuals, on iron metabolism, oxidative balance, and antioxidant plasma capacity, using doses similar to the daily nutritional requirement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Oxidative Stress, Iron Metabolism Disorders
CountriesVenezuela
CollaboratorsSeguros Caracas Foundation, National Fund for Science and Technology, Science Mission

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 22, 2011
Enrollment StartJan 1, 2010
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 14.6 years ago

Interventions

Betacarotenedietary

6 mg betacarotene in caplets for 45 days (daily)and reevaluate parameters 30 days after finishing supplementation

Controls. No treatmentdietary

Evaluate at time 0, 45 days and 75 days, but without receiving betacarotene supplements